Coronavirus Stocks List

Recent Signals

Date Stock Signal Type
2021-03-01 AEMD Narrow Range Bar Range Contraction
2021-03-01 AHPI Narrow Range Bar Range Contraction
2021-03-01 AHPI NR7 Range Contraction
2021-03-01 ALGS Doji - Bearish? Reversal
2021-03-01 ALGS 50 DMA Support Bullish
2021-03-01 ALGS NR7 Range Contraction
2021-03-01 APT Crossed Above 50 DMA Bullish
2021-03-01 AZN Lower Bollinger Band Walk Weakness
2021-03-01 BCRX New 52 Week Closing High Bullish
2021-03-01 BCRX MACD Bullish Signal Line Cross Bullish
2021-03-01 CBLI Stochastic Buy Signal Bullish
2021-03-01 CERS Stochastic Buy Signal Bullish
2021-03-01 CERS 200 DMA Resistance Bearish
2021-03-01 CVAC Narrow Range Bar Range Contraction
2021-03-01 CVAC NR7 Range Contraction
2021-03-01 HGEN 50 DMA Resistance Bearish
2021-03-01 HGEN Stochastic Buy Signal Bullish
2021-03-01 HGEN Narrow Range Bar Range Contraction
2021-03-01 HGEN NR7 Range Contraction
2021-03-01 ICCC Crossed Above 20 DMA Bullish
2021-03-01 ICCC 180 Bullish Setup Bullish Swing Setup
2021-03-01 INO Crossed Above 50 DMA Bullish
2021-03-01 INO Narrow Range Bar Range Contraction
2021-03-01 LAKE NR7-2 Range Contraction
2021-03-01 LAKE NR7 Range Contraction
2021-03-01 NFH New 52 Week Closing High Bullish
2021-03-01 NFH New 52 Week High Strength
2021-03-01 NFH Spinning Top Other
2021-03-01 NNVC NR7 Range Contraction
2021-03-01 NNVC Narrow Range Bar Range Contraction
2021-03-01 VXRT Narrow Range Bar Range Contraction
2021-03-01 XAIR 50 DMA Resistance Bearish
2021-03-01 XAIR 200 DMA Resistance Bearish
2021-03-01 XAIR MACD Bearish Centerline Cross Bearish
2021-03-01 XAIR New Uptrend Bullish
2021-03-01 XAIR 20 DMA Resistance Bearish

Recent News for Coronavirus Stocks

Date Stock Title
Mar 1 INO Inovio shares slip afterhours despite positive phase 3 results for VGX-3100
Mar 1 INO Recap: Inovio Pharmaceuticals Q4 Earnings
Mar 1 INO UPDATE 1-Inovio completes enrolment in mid-stage U.S. study of COVID-19 vaccine
Mar 1 INO Inovio Pharmaceuticals EPS beats by $0.08, beats on revenue
Mar 1 INO INOVIO Reports Fourth Quarter 2020 and Year-End Financial Results
Mar 1 NVAX Novavax EPS misses by $0.46, beats on revenue
Mar 1 NVAX Novavax COVID-19 shot could be cleared for U.S. use as early as May -CEO
Mar 1 NVAX Novavax Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
Mar 1 INO INOVIO Announces Positive Results from REVEAL 1, a Phase 3 Pivotal Trial Evaluating VGX-3100, its DNA-based HPV Immunotherapy for the Treatment of High-grade Precancerous Cervical Dysplasia Caused by HPV-16 and/or HPV-18
Mar 1 AZN FibroGen Provides Regulatory Update on Roxadustat
Mar 1 AZN France eases ban on AstraZeneca vaccine for over-65s
Mar 1 MRNA Genpact’s AI platform to process and track 'adverse events' of COVID-19 vaccine
Mar 1 GILD Genpact’s AI platform to process and track 'adverse events' of COVID-19 vaccine
Mar 1 AZN Genpact’s AI platform to process and track 'adverse events' of COVID-19 vaccine
Mar 1 NVAX Genpact’s AI platform to process and track 'adverse events' of COVID-19 vaccine
Mar 1 MRNA EU to propose COVID-19 ‘vaccine certificates’ to promote cross-border travel
Mar 1 AZN EU to propose COVID-19 ‘vaccine certificates’ to promote cross-border travel
Mar 1 BCRX Why BioCryst Pharmaceuticals Stock Is Popping Today
Mar 1 NVAX Vaccine Acceptance Rises As Americans Eye Covid Mutations: IBD/TIPP Poll
Mar 1 AZN Chile to ramp up purchase of Sinovac vaccine, seeking deal with Johnson & Johnson

Coronaviruses are a group of viruses that cause diseases in mammals and birds. In humans, coronaviruses cause respiratory tract infections that are typically mild, such as the common cold, though rarer forms such as SARS, MERS, and COVID-19 can be lethal. Symptoms vary in other species: in chickens, they cause an upper respiratory tract disease, while in cows and pigs they cause diarrhea. There are yet to be vaccines or antiviral drugs to prevent or treat human coronavirus infections.

More about Coronavirus
Browse All Tags